Biotechnology stocks
1,362 listed biotechnology companies, ordered by market capitalisation, inside the Health Care sector. Every one has a free page with its price history, key figures and Tweenvest factor scores.
| Company | Market cap | Price | Day |
|---|---|---|---|
| Pasithea Therapeutics Corp.NasdaqCM: KTTA | $14.03M | $0.42 | -10.16% |
| Xintela AB (publ)OM: XINT | $14.00M | Skr0.16 | -10.31% |
| BioCardia, Inc.NasdaqCM: BCDA | $13.93M | $0.92 | -11.53% |
| Biophytis S.A.ENXTPA: ALBPS | $13.57M | €0.03 | +8.81% |
| Genflow Biosciences plcLSE: GENF | $13.22M | £0.02 | -1.41% |
| Alzinova AB (publ)OM: ALZ | $13.21M | Skr0.43 | -1.96% |
| Genomed Spólka AkcyjnaWSE: GEN | $13.14M | zł38.60 | -3.50% |
| Imugene LimitedASX: IMU | $13.09M | AU$0.04 | -2.56% |
| TME Pharma N.V.ENXTPA: ALTME | $13.07M | €0.12 | +12.32% |
| Genomtec S.A.WSE: GMT | $12.72M | zł2.90 | -5.70% |
| Algorae Pharmaceuticals LimitedASX: 1AI | $12.70M | AU$0.01 | +12.50% |
| America Great HealthOTCPK: AAGH | $12.69M | $0.00 | +100.00% |
| GT Biopharma, Inc.NasdaqCM: GTBP | $12.68M | $7.03 | +5.24% |
| Cerenome, Inc.NasdaqCM: CNSY | $12.45M | $1.64 | -6.29% |
| Verici Dx plcAIM: VRCI | $12.45M | £0.00 | +4.44% |
| Clal Biotechnology Industries Ltd.TASE: CBI | $12.34M | ₪0.24 | +2.52% |
| Synlogic, Inc.OTCPK: SYBX | $12.25M | $1.00 | -9.09% |
| NextCell Pharma ABOM: NXTCL | $12.20M | Skr0.96 | -5.53% |
| Radiopharm Theranostics LimitedASX: RAD | $12.07M | AU$0.00 | -20.00% |
| Pharmala Biotech Holdings Inc.CNSX: MDMA | $12.02M | CA$0.16 | -27.91% |
| EOM Pharmaceuticals Holdings, Inc.OTCPK: IMUC | $12.02M | $0.10 | -40.21% |
| Karyopharm Therapeutics Inc.NasdaqGS: KPTI | $11.74M | $0.52 | -5.27% |
| AEON Biopharma, Inc.NYSEAM: AEON | $11.57M | $0.23 | -15.94% |
| BioLineRx Ltd.TASE: BLRX | $11.56M | ₪0.01 | -7.69% |
| Eagle Pharmaceuticals, Inc.OTCPK: EGRX | $11.53M | $0.89 | -8.76% |
| Aelis Farma SAENXTPA: AELIS | $11.50M | €0.75 | -5.88% |
| Pluri Inc.NasdaqCM: PLUR | $11.48M | $0.93 | -2.44% |
| Celyad Oncology SAENXTBR: CYAD | $11.43M | €0.23 | +13.50% |
| NGeneBio Co., Ltd.KOSDAQ: A354200 | $11.31M | ₩937.00 | +18.91% |
| Pharmigene, Inc.TPEX: 7595 | $11.28M | NT$7.25 | -2.03% |
| Passage Bio, Inc.NasdaqCM: PASG | $11.26M | $3.50 | -5.15% |
| Patrys LimitedASX: PAB | $11.06M | AU$0.03 | -3.57% |
| IN8bio, Inc.NasdaqCM: INAB | $10.94M | $1.11 | -17.16% |
| Intensity Therapeutics, Inc.NasdaqCM: INTS | $10.94M | $3.35 | -7.71% |
| Cellectar Biosciences, Inc.NasdaqCM: CLRB | $10.78M | $1.14 | -21.38% |
| Noxopharm LimitedASX: NOX | $10.69M | AU$0.05 | -18.03% |
| CytoMed Therapeutics LimitedNasdaqCM: GDTC | $10.50M | $0.88 | -1.13% |
| Palatin Technologies, Inc.LSE: 0KF3 | $10.49M | $5.89 | +1.55% |
| Ceryvyn Therapeutics LimitedASX: CYV | $10.47M | AU$0.01 | -15.38% |
| Regentis Biomaterials Ltd.NYSEAM: RGNT | $10.47M | $1.49 | -6.88% |
| Tempest Therapeutics, Inc.NasdaqCM: TPST | $10.32M | $0.62 | -17.88% |
| Phio Pharmaceuticals Corp.NasdaqCM: PHIO | $10.12M | $0.87 | -11.00% |
| Ensysce Biosciences, Inc.NasdaqCM: ENSC | $10.08M | $0.52 | -1.65% |
| China Regenerative Medicine International LimitedSEHK: 8158 | $9.89M | HK$0.26 | -17.74% |
| Theriva Biologics, Inc.NYSEAM: TOVX | $9.54M | $0.21 | -4.19% |
| Nextage Therapeutics LtdTASE: NXTG | $9.54M | ₪0.37 | -3.95% |
| Solvonis Therapeutics plcLSE: SVNS | $9.53M | £0.00 | -4.76% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.51M | £0.09 | -2.70% |
| PeopleBio, Inc.KOSDAQ: A304840 | $9.47M | ₩— | — |
| AtonENXTPA: ALTAO | $9.46M | €0.01 | -5.56% |
| Lisata Therapeutics, Inc.NasdaqCM: LSTA | $9.28M | $1.03 | -2.83% |
| Celestra Inc.KOSDAQ: A352770 | $9.28M | ₩— | — |
| Cambium Bio LimitedASX: CMB | $9.22M | AU$0.45 | -16.67% |
| Spago Nanomedical AB (publ)OM: SPAGO | $9.19M | Skr0.11 | +12.32% |
| BioVie Inc.NasdaqCM: BIVI | $9.05M | $1.20 | -13.67% |
| Hemostemix Inc.TSXV: HEM | $8.97M | CA$0.06 | -20.00% |
| Poxel S.A.ENXTPA: POXEL | $8.95M | €0.15 | +10.45% |
| AdAlta LimitedASX: 1AD | $8.94M | AU$0.00 | +14.29% |
| Biovica International AB (publ)OM: BIOVIC B | $8.90M | Skr0.30 | -0.33% |
| Vistagen Therapeutics, Inc.NasdaqCM: VTGN | $8.88M | $0.20 | -15.29% |
| 1nKemia IUCT Group, S.A.BME: IKM | $8.80M | €— | — |
| Nanologica AB (publ)OM: NICA | $8.66M | Skr0.26 | -5.78% |
| Brainstorm Cell Therapeutics Inc.OTCPK: BCLI | $8.60M | $0.78 | -17.94% |
| Chemomab Therapeutics Ltd.NasdaqCM: CMMB | $8.55M | $1.18 | +0.85% |
| Lantern Pharma Inc.NasdaqCM: LTRN | $8.54M | $0.67 | -17.76% |
| Adaptimmune Therapeutics plcOTCPK: ADAP.Y | $8.48M | $0.03 | +6.67% |
| Eusol Biotech Co.,Ltd.UNQ: 6652 | $8.45M | NT$— | — |
| Active Biotech AB (publ)OM: ACTI | $8.34M | Skr3.14 | -10.94% |
| MetaVia Inc.NasdaqCM: MTVA | $8.30M | $1.26 | -10.64% |
| MOA Life Plus Co. Ltd.KOSDAQ: A142760 | $8.22M | ₩520.00 | +0.78% |
| NFL Biosciences SAENXTPA: ALNFL | $8.08M | €0.57 | -8.55% |
| Vivesto ABOM: VIVE | $8.06M | Skr7.21 | -3.74% |
| OSR Health, Inc.OTCPK: OSRH | $7.94M | $0.23 | +15.90% |
| Delta-Fly Pharma, Inc.TSE: 4598 | $7.86M | ¥84.00 | -15.15% |
| OptiBiotix Health PlcAIM: OPTI | $7.79M | £0.06 | -4.24% |
| Bolt Biotherapeutics, Inc.NasdaqCM: BOLT | $7.71M | $4.00 | -2.68% |
| Soligenix, Inc.NasdaqCM: SNGX | $7.69M | $0.35 | -2.89% |
| Immuron LimitedASX: IMC | $7.64M | AU$0.03 | -24.44% |
| Oncotelic Therapeutics, Inc.OTCPK: OTLC | $7.59M | $0.02 | -20.19% |
| Ascelia Pharma AB (publ)OM: ACE | $7.58M | Skr0.56 | -34.65% |
| Aprea Therapeutics, Inc.NasdaqCM: APRE | $7.36M | $0.58 | -3.34% |
| Exicure, Inc.NasdaqCM: XCUR | $7.33M | $1.12 | +6.67% |
| Oncodesign Precision Medicine Société anonymeENXTPA: ALOPM | $7.30M | €0.34 | +3.33% |
| Prostatype Genomics AB (publ)OM: PROGEN | $7.26M | Skr0.10 | +13.29% |
| Zeo ScientifiX, Inc.OTCPK: ZEOX | $7.14M | $0.91 | -23.11% |
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $7.00M | $0.22 | -28.47% |
| Rakovina Therapeutics Inc.TSXV: RKV | $6.93M | CA$0.22 | -2.22% |
| Skye Bioscience, Inc.NasdaqCM: SKYE | $6.86M | $1.55 | -8.28% |
| CollPlant Biotechnologies Ltd.NasdaqCM: CLGN | $6.85M | $3.63 | +3.28% |
| FibroBiologics, Inc.NasdaqCM: FBLG | $6.75M | $0.97 | -14.07% |
| Alaunos Therapeutics, Inc.NasdaqCM: TCRT | $6.68M | $2.63 | +234.69% |
| Arctic Bioscience ASOB: ABS | $6.59M | Nkr2.31 | -12.50% |
| VitaSpring Biomedical Co. Ltd.OTCPK: VSBC | $6.58M | $0.03 | — |
| AcouSort AB (publ)OM: ACOU | $6.54M | Skr3.06 | +2.00% |
| Curative Biotechnology, Inc.OTCPK: CUBT | $6.50M | $0.91 | -4.27% |
| Subgen AI AB (publ)OM: SUBGEN | $6.44M | Skr0.03 | +7.33% |
| XTL Biopharmaceuticals Ltd.TASE: XTLB | $6.41M | ₪0.02 | -6.25% |
| Theracryf PlcAIM: TCF | $6.38M | £0.00 | +2.94% |
| Moleculin Biotech, Inc.NasdaqCM: MBRX | $6.33M | $6.50 | +10.36% |
| Alzamend Neuro, Inc.NasdaqCM: ALZN | $6.27M | $1.30 | -2.99% |